Skip to content

Catherine Ledent

4 papers in the library · 33 citations · publishing 1999-2011

Papers

Sort Most recent Most cited

The A2a adenosine receptor modulates the reinforcement efficacy and neurotoxicity of MDMA

Journal of Psychopharmacology January 24, 2011 Jéssica Ruiz‐medina, Catherine Ledent, Olga Carretón et al. 33 citations

Adenosine is an endogenous purine nucleoside that plays a neuromodulatory role in the central nervous system. A2a adenosine receptors have been involved in reward-related processes, inflammatory phenomena and neurotoxicity reactions. In the present study, we investigated the role of A2a adenosine receptors on the acute pharmacological effects, reinforcement and neuroinflammation induced by MDMA...

DOI: 10.1177/0269881110389210 (opens in new tab) MDMA Neurotoxicity Adenosine a2a receptor Pharmacology +6

CB1 cannabinoid receptor modulates 3,4-methylenedioxymethamphetamine acute responses and reinforcement.

Biological Psychiatry June 1, 2008 Clara Touriño, Catherine Ledent, Rafaël Maldonado et al.

3,4-Methylenedioxymethamphetamine (MDMA) is a popular recreational drug widely abused by young people. The endocannabinoid system is involved in the addictive processes induced by different drugs of abuse. However, the role of this system in the pharmacological effects of MDMA has not yet been clarified. Locomotion, body temperature, and anxiogenic-like responses were evaluated after acute MDMA...

Adenosine A2A receptors are involved in physical dependence and place conditioning induced by THC.

European Journal of Neuroscience October 2004 Guadalupe Soria, Anna Castañé, Fernando Berrendero et al.

A2A adenosine and CB1 cannabinoid receptors are highly expressed in the central nervous system, where they modulate numerous physiological processes including adaptive responses to drugs of abuse. Both purinergic and cannabinoid systems interact with dopamine neurotransmission (through A2A and CB1 receptors, respectively). Changes in dopamine neurotransmission play an important role in...

Unresponsiveness to cannabinoids and reduced addictive effects of opiates in CB1 receptor knockout mice.

Science January 15, 1999 Catherine Ledent, Olga Valverde, G Cossu et al.

The function of the central cannabinoid receptor (CB1) was investigated by invalidating its gene. Mutant mice did not respond to cannabinoid drugs, demonstrating the exclusive role of the CB1 receptor in mediating analgesia, reinforcement, hypothermia, hypolocomotion, and hypotension. The acute effects of opiates were unaffected, but the reinforcing properties of morphine and the severity of...